Judy Kay Frieder, CEAC, CSA, ECHMP, CLIPP’s Post

Great news for the #bostonmetro #biotech and #pharma industries driving innovation and new therapeutic research. The reauthorizing of the Life Sciences Initiative promises to build on the success of the program that has made Massachusetts a global leader in this critical industry. #lifesciencesindustry #lifesciecesinitiative #innovation #researchanddevelopment #massbio

Great news for the #bostonmetro #biotech and #pharma industries driving innovation and new therapeutic research. The reauthorizing of the Life Sciences Initiative promises to build on the success of the program that has made Massachusetts a global leader in this critical industry. #lifesciencesindustry #lifesciecesinitiative #innovation #researchanddevelopment #massbio

📢 ALERT RESEARCH GRANT OPPORTUNITY - Surrey Academic Health and Care Partnership (SAHCP) Energise Fund, will support evidence-based, multidisciplinary projects of a value between £50,000–£75,000. 🔦 If you need to improve your grant writing skills I'm running an online workshop on 19th September from 8.30 - 10am. Drop me a comment or message if you'd like more info. Summary of Energise Fund - need to be UK organisations based in Surrey and lead applicant needs to be NHS organisation, higher education institution or Surrey County Council within SAHCP area. Closing date - 25th September 2024. The fund seeks to improve healthcare services in ‘out-of-hospital’ settings to deliver care that’s more cost-effective and convenient for patients. It also focuses on early detection in healthcare by advancing preventative care to effectively address health risks before they escalate.  https://lnkd.in/eagXRx64

Willa Bluestone, Director of Workforce and Policy Strategies at the Ohio Life Sciences (OLS), is a tireless advocate for policies that fuel innovation and growth in our state's life sciences industry. This year, she's laser-focused on maximizing the SBIR/STTR State Matching Program. What is the SBIR/STTR Match? This program encourages Ohio small businesses to apply for federal research grants by providing matching funds for grant recipients. Additionally, the program would support small businesses developing cutting-edge life sciences technologies by amplifying R&D efforts, fostering job creation, and propelling Ohio to the forefront of innovation. Why should you care? Accelerates groundbreaking research: The Match unlocks critical resources, speeding up breakthroughs and getting life-saving solutions to patients faster. Strengthens Ohio's life sciences ecosystem: It attracts and retains top talent, fostering a vibrant hub for innovation and investment. Creates high-paying jobs: By supporting R&D, the Match fuels job growth in our state's most promising sectors. Want to learn more and get involved? Schedule a 15-minute chat with Willa! She'll answer your questions, share success stories, and discuss how you can advocate for the SBIR/STTR Match and empower Ohio's life sciences future. Click the link to book your call: https://lnkd.in/gkhYHXVz #OhioLifeSciences #SBIRSTTRMatch #Advocacy

🚀 "Triumphs & Trials: Young Medical Delta's Bold Leap from Setbacks to Thesis Awards Success!" 🌟 In every journey, especially one driven by innovation and ambition, setbacks and mistakes are not just inevitable – they're essential. Today, we want to share a story of resilience, learning, and ultimately, triumph. 🔄 A Lesson in Adaptation Back in September, we faced a challenge. Our planned Thesis Awards had to be postponed due to fewer sign-ups than anticipated. It was a moment of reflection for us at Young Medical Delta. Yes, we could have done some things better. And that's exactly what we set out to do. 💡 Young at Heart, Rich in Learning Our name, 'Young' Medical Delta, isn't just a title. It symbolizes our ethos. Being 'young' means constantly evolving, embracing the growth that comes from every experience, and yes, learning from our mistakes. We are a community that is youthful, not just in age, but in spirit – resilient, adaptable, and ever-learning. 🚀 The Power of Resilience We promised ourselves that we would come back stronger, and we did. With renewed energy and strategies, we turned a setback into an opportunity for growth. The result? A record number of sign-ups for the rescheduled Thesis Awards on January 18, 2024. This isn't just a number; it's a testament to our community's belief in us and our mission. 🚀 Looking Forward to Our Next Mistakes Yes, you read that right! We are looking forward to our next mistakes – each one is an opportunity to grow, innovate, and push boundaries. Bring it on, because with every challenge, we become stronger, wiser, and more prepared for the future. 🎉 Raising a Toast to Your 2023 Missteps! Mistakes in 2023? Tell us about them, and let's have a toast! In the world of Young Medical Delta, every slip-up is a confetti moment in our shared journey of growth and learning. Here's to more breakthroughs, shared learning experiences, and, most importantly, toasting to every lesson learned along the way! 🥂 #Resilience #GrowthMindset #LearningFromSetbacks #ThesisAwards #YoungMedicalDelta #InnovationJourney

Excellent insights were uncovered in this recent poll conducted by Duncan McDonald! What are your thoughts on this? Were you anticipating that 'eligibility criteria' would surpass 'limited awareness' as the primary obstacle in trial recruitment? #clinicalresearch #clinicaltrials #decentralisedclinicaltrials #researchinnovation #patientengagement #patientrecruitment #patientretention #unifiedprotocol

Highlighting this work led by my colleague, Will Cragg, about developing resources for participants who withdraw from clinical trials. Stopping participation can be a tough process for participants. People have reported feeling 'abandoned', or find it difficult to communicate reasons for stopping participation, or communication from research staff about what happens as a result of stopping participation, makes it more difficult. But the work hadn't really been explored in depth, and we found that sometimes participants can be excluded from important communications like study results without clear justification. A co-developed resource to provide support to research participants who stop taking part was produced. I really enjoyed being involved, particularly being led by Will and watching him manage this project with a group of public contributors whose experience and skills were essential to informing the direction of the work. Have a read and check out the PeRSEVERE website, developed by Will, for guidance and resources for handling end of participation https://lnkd.in/e__Fr-9U Full paper here: https://lnkd.in/e4MJn39S #trialconduct #ppie #clinicaltrials #research

For systematic literature reviews, evidence synthesis and HTA needs in the HEOR space your search is over.

I’m continuously impressed by the outstanding leadership at iRhythm Technologies, Inc. One particular stand out is Paula Miller, Director of DEI. She recently presented at our Global Sales Meeting on identifying your own implicit bias and the impact it can have on others around you. It’s fantastic to see industry taking initiatives for this important discussion. As health professionals, we also need to take the time to better understand implicit bias as it directly relates to patient care outcomes. I’d highly recommend taking the time to understand your own implicit bias through taking Project Implicit’s exam: https://lnkd.in/gjmjCh-N. Closing the disparity gap in healthcare can only be achieved if we are able to understand the role our own implicit bias has in preventing us from delivering equitable patient care.

👀 Did you see this? 👀 The #AustralianGovernment has committed a further $6.5 billion for health and medical research funding via the Medical Research Future Fund (#MRFF), by releasing their 3rd 10-year Investment Plan (2024-25 to 2033-34). The Investment Plan details the level of financial support for 22 initiatives between 2024-25 and 2033-34, under the umbrella of four main themes (Patients, Research Missions, Researchers, and Research Translation). Through these #initiatives, the #InvestmentPlan seeks to “continue to support lifesaving research, create jobs, strengthen the local industry base for commercialising research and innovation, and further grow Australia’s reputation as a world leader in medical research.” 🔬 WHAT’S NEW: There are two new Research Missions, valued at $97.2M each: the Low Survival Cancer Mission, to improve care and health outcomes for individuals with low survival cancer, and the Reducing Health Inequities Mission, to address inequities in health outcomes by improving access to quality health services by prioritising populations. WHAT’S STILL THE SAME: The funding commitments remain largely unchanged from the 2nd 10-year Investment Plan, despite calls from the Association of Australian Medical Research Institutes (AAMRI) and others for additional funds to support the indirect costs of research. Read the full 3rd 10-year Investment Plan here: https://lnkd.in/gMD5nYgn #MedicalResearchFutureFund #NHMRC #InvestmentPlan #Research #ResearchFunding #MedicalScience #HealthAndMedicalResearch #AustralianGovernment #DepartmentOfAgedCare #ResearchMissions #ClinicalTrials #ResearchPriorities #Funding #Innovation #HealthServices #HealthOutcomes #TranslationalResearch #Consulting #Research Bernadette Spinks Darren Cundy Greg Spinks Mike (Pep) Pepperell Australian Government Department of Health and Aged Care